217 results on '"Dhere, Tanvi"'
Search Results
2. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease.
3. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience
4. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis
5. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.
6. Integration of Radiation Oncology Into the Preclinical Curriculum Through Problem-Based Learning
7. What Are My Options? Introducing Health Professional Students to Subspecialties
8. Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans
9. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection
10. First Case of Refractory Colitis Caused by Ocrelizumab
11. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
12. Acute Gastrointestinal Bleeding
13. S1000 Differences in Work Disability by Race and Gender in Patients With Inflammatory Bowel Disease
14. S1063 Corticosteroid Use in Inflammatory Bowel Disease (IBD) Patients May Lead to Worse IBD-Related Outcomes After COVID-19 Infection
15. Problem-Based Learning Curriculum as a Tool to Increase Medical Student Exposure to Radiation Oncology
16. Pediatric short bowel syndrome and subsequent development of inflammatory bowel disease: an illustrative case and literature review
17. Chronic Diarrheal Disorders due to Endocrine Neoplasms
18. IBD Serology and Disease Outcomes in African Americans With Crohn’s Disease
19. Ulcerative Colitis: Update on Medical Management
20. Fecal Microbiota Transplant for Clostridium difficile Infection in a Pregnant Patient
21. Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients
22. P026 Inflammatory Bowel Disease (IBD) Related Outcomes in Patients Diagnosed With COVID-19
23. P026 Inflammatory Bowel Disease (IBD) Related Outcomes in Patients Diagnosed With COVID-19
24. Corrigendum to: Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies
25. Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies
26. S3355 Inflammatory Bowel Disease (IBD) Patients in Remission at the Time of COVID-19 Diagnosis Have Better IBD Related Outcomes Than Those With Moderate Disease Activity at the Time of COVID-19 Diagnosis
27. A comparison of abdominal surgical outcomes between African–American and Caucasian Crohn’s patients
28. Earlier use of fecal transplant administration during hospitalization for Clostridioides difficile infectionmay improve outcome
29. Autoimmune Enteropathy Presenting as Ascites in a Patient With Cirrhosis
30. Diagnostic and therapeutic considerations for obscure gastrointestinal bleeding in patients with chronic kidney disease
31. Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.
32. Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile
33. Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report
34. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
35. Acute Gastrointestinal Bleeding
36. Chronic Diarrheal Disorders due to Endocrine Neoplasms
37. Tu1574 ROLE OF DEVICE ASSISTED ENTEROSCOPY IN SMALL BOWEL BLEEDING IN PATIENTS WITH CHRONIC KIDNEY DISEASE
38. Mo1948 OUTCOMES OF INPATIENT FECAL TRANSPLANT ADMINISTRATION FOR CLOSTRIDIODES DIFFICILE INFECTION (CDI)
39. Crohnʼs Disease in an African-American Population
40. Mo1954 – Fecal Microbiota Transplantation is Safe and Effective for the Treatment of Clostridium Difficile Infection in Patients with Liver Cirrhosis
41. Su1028 – Whole-Genome Sequencing of African Americans Identifies Novel Rare Variants Associated with Inflammatory Bowel Disease
42. Tu1863 – Differences Among Luminal and Mucosal Microbiota Among Fecal Microbiota Transplant Recipients
43. Neuropeptide Y Receptor Y1 (NPY Y1) Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Human IBD Biopsy Cultures
44. 109. Differences in Gram-Negative Antibiotic Susceptibility Among Patients Receiving Fecal Microbiota Transplant for Clostridioides difficile
45. Role of Race in Loss of Response to Infusion Biologics in Patients With Inflammatory Bowel Disease
46. Race Differences in IBD: A Study of Quality of Life, Work Productivity, and Endoscopic Severity
47. Catastrophic Phlegmasia Cerulea Dolens in Inflammatory Bowel Disease
48. Thrombotic Cutaneous Gangrene: A Rare Dermatologic and Hematologic Extraintestinal Manifestation of Ulcerative Colitis
49. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
50. Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.